StoneRidge PMG Advisors LLC Purchases 1,103 Shares of Waters Corporation $WAT

StoneRidge PMG Advisors LLC acquired a new stake in Waters Corporation (NYSE:WAT) during the third quarter, according to its most recent filing with the SEC. The firm acquired 1,103 shares of the medical instruments supplier’s stock, valued at approximately $485,000.

Several other institutional investors also recently bought and sold shares of the company. California Public Employees Retirement System grew its stake in shares of Waters by 25.4% during the 1st quarter. California Public Employees Retirement System now owns 138,423 shares of the medical instruments supplier’s stock worth $41,222,000 after purchasing an additional 28,074 shares during the period. Dudley & Shanley Inc. lifted its stake in shares of Waters by 101.3% in the second quarter. Dudley & Shanley Inc. now owns 23,590 shares of the medical instruments supplier’s stock valued at $8,847,000 after purchasing an additional 11,870 shares during the period. Hahn Capital Management LLC acquired a new stake in shares of Waters in the first quarter valued at about $1,490,000. Handelsbanken Fonder AB lifted its stake in shares of Waters by 93.1% in the second quarter. Handelsbanken Fonder AB now owns 93,653 shares of the medical instruments supplier’s stock valued at $35,124,000 after purchasing an additional 45,145 shares during the period. Finally, OVERSEA CHINESE BANKING Corp Ltd boosted its holdings in Waters by 18.4% during the second quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 95,028 shares of the medical instruments supplier’s stock worth $35,639,000 after buying an additional 14,754 shares in the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

More Waters News

Here are the key news stories impacting Waters this week:

• Positive Sentiment: Waters reported $1.77 billion in third-quarter 2026 revenue and raised its full-year guidance, signaling improved expectations for the business. Waters Corporation Reports $1.77 Billion in Third Quarter 2026 Revenue and Raises Full-Year Guidance
• Positive Sentiment: The company agreed to acquire MOBILion Systems, expanding its mass spectrometry and AI-powered proteomics capabilities. The strategic fit could broaden Waters’ technology offering, though the reported item does not quantify the deal’s financial impact. Waters Corporation Acquires MOBILion Systems
• Positive Sentiment: JPMorgan, Barclays, KeyCorp, TD Cowen, Citigroup, and RBC issued reports indicating higher price targets or strong potential appreciation, reinforcing a favorable analyst outlook. JPMorgan price target Barclays outlook KeyCorp outlook TD Cowen price target Citigroup price target RBC outlook

Analyst Ratings Changes

Several research analysts have weighed in on the stock. The Goldman Sachs Group upped their target price on shares of Waters from $465.00 to $515.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Guggenheim lifted their price target on shares of Waters from $440.00 to $490.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. Deutsche Bank Aktiengesellschaft boosted their price target on Waters from $400.00 to $440.00 in a research note on Thursday, October 15th. Citigroup upped their price target on Waters from $470.00 to $536.00 and gave the stock a “buy” rating in a report on Wednesday, November 4th. Finally, Sanford C. Bernstein restated an “outperform” rating and issued a $535.00 price target on shares of Waters in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, Waters currently has a consensus rating of “Moderate Buy” and an average target price of $475.48.

Waters Stock Performance

Shares of WAT opened at $457.92 on Monday. The company has a current ratio of 0.66, a quick ratio of 0.40 and a debt-to-equity ratio of 0.32. The stock has a market cap of $44.99 billion, a P/E ratio of 196.53, a PEG ratio of 2.60 and a beta of 1.16. The company has a 50-day moving average of $434.72 and a two-hundred day moving average of $372.24. Waters Corporation has a 12-month low of $282.77 and a 12-month high of $482.28.

Waters (NYSE:WAT) last announced its quarterly earnings results on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.00 by $0.10. The company had revenue of $1.77 billion for the quarter, compared to the consensus estimate of $1.75 billion. Waters had a net margin of 1.75% and a return on equity of 9.91%. The company’s revenue for the quarter was up 120.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $3.40 earnings per share. As a group, research analysts predict that Waters Corporation will post 14.65 EPS for the current fiscal year.

Waters Company Profile

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples.

The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Founded in 1958 by James L.